Literature DB >> 29333521

Nanomaterials for convection-enhanced delivery of agents to treat brain tumors.

Young-Eun Seo1, Tom Bu1, W Mark Saltzman1.   

Abstract

Nanomaterials represent a promising and versatile platform for the delivery of therapeutics to the brain. Treatment of brain tumors has been a long-standing challenge in the field of neuro-oncology. The current standard of care - a multimodal approach of surgery, radiation and chemotherapy - yields only a modest therapeutic benefit for patients with malignant gliomas. A major obstacle for treatment is the failure to achieve sufficient delivery of therapeutics at the tumor site. Recent advances in local drug delivery techniques, along with the development of highly effective brain-penetrating nanocarriers, have significantly improved treatment and imaging of brain tumors in preclinical studies. The major advantage of this combined strategy is the ability to optimize local therapy, by maintaining an effective and sustained concentration of therapeutics in the brain with minimal systemic toxicity. This review highlights some of the latest developments, significant advancements and current challenges in local delivery of nanomaterials for the treatment of brain tumors.

Entities:  

Keywords:  Convection-enhanced delivery; Glioblastoma; Local therapy; Nanocarriers

Year:  2017        PMID: 29333521      PMCID: PMC5761746          DOI: 10.1016/j.cobme.2017.09.002

Source DB:  PubMed          Journal:  Curr Opin Biomed Eng        ISSN: 2468-4511


  99 in total

1.  Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.

Authors:  Matthias Van Woensel; Nathalie Wauthoz; Rémi Rosière; Véronique Mathieu; Robert Kiss; Florence Lefranc; Brecht Steelant; Ellen Dilissen; Stefaan W Van Gool; Thomas Mathivet; Holger Gerhardt; Karim Amighi; Steven De Vleeschouwer
Journal:  J Control Release       Date:  2016-02-21       Impact factor: 9.776

2.  Poor drug distribution as a possible explanation for the results of the PRECISE trial.

Authors:  John H Sampson; Gary Archer; Christoph Pedain; Eva Wembacher-Schröder; Manfred Westphal; Sandeep Kunwar; Michael A Vogelbaum; April Coan; James E Herndon; Raghu Raghavan; Martin L Brady; David A Reardon; Allan H Friedman; Henry S Friedman; M Inmaculada Rodríguez-Ponce; Susan M Chang; Stephan Mittermeyer; David Croteau; Raj K Puri
Journal:  J Neurosurg       Date:  2010-08       Impact factor: 5.115

3.  Biodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the Brain.

Authors:  Panagiotis Mastorakos; Eric Song; Clark Zhang; Sneha Berry; Hee Won Park; Young Eun Kim; Jong Sung Park; Seulki Lee; Jung Soo Suk; Justin Hanes
Journal:  Small       Date:  2015-12-17       Impact factor: 13.281

4.  Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain.

Authors:  Ryuta Saito; Michal T Krauze; John R Bringas; Charles Noble; Tracy R McKnight; Pamela Jackson; Michael F Wendland; Christoph Mamot; Daryl C Drummond; Dimitri B Kirpotin; Keelung Hong; Mitchel S Berger; John W Park; Krystof S Bankiewicz
Journal:  Exp Neurol       Date:  2005-09-28       Impact factor: 5.330

5.  Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.

Authors:  Thibaut Fourniols; Luc D Randolph; Aurélie Staub; Kevin Vanvarenberg; Julian G Leprince; Véronique Préat; Anne des Rieux; Fabienne Danhier
Journal:  J Control Release       Date:  2015-05-15       Impact factor: 9.776

Review 6.  Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma.

Authors:  C Bastiancich; P Danhier; V Préat; F Danhier
Journal:  J Control Release       Date:  2016-09-28       Impact factor: 9.776

Review 7.  Convection-enhanced delivery of nanocarriers for the treatment of brain tumors.

Authors:  Emilie Allard; Catherine Passirani; Jean-Pierre Benoit
Journal:  Biomaterials       Date:  2009-01-24       Impact factor: 12.479

8.  Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo.

Authors:  Antonella Mangraviti; Stephany Yi Tzeng; Kristen Lynn Kozielski; Yuan Wang; Yike Jin; David Gullotti; Mariangela Pedone; Nitsa Buaron; Ann Liu; David R Wilson; Sarah K Hansen; Fausto J Rodriguez; Guo-Dong Gao; Francesco DiMeco; Henry Brem; Alessandro Olivi; Betty Tyler; Jordan J Green
Journal:  ACS Nano       Date:  2015-02-10       Impact factor: 15.881

Review 9.  The future of glioblastoma therapy: synergism of standard of care and immunotherapy.

Authors:  Mira A Patel; Jennifer E Kim; Jacob Ruzevick; Gordon Li; Michael Lim
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

Review 10.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Authors:  Amanda Shea; Varsha Harish; Zainab Afzal; Juliet Chijioke; Habib Kedir; Shahnoza Dusmatova; Arpita Roy; Malathi Ramalinga; Brent Harris; Jan Blancato; Mukesh Verma; Deepak Kumar
Journal:  Cancer Med       Date:  2016-06-10       Impact factor: 4.452

View more
  8 in total

1.  Widespread gene transfer to malignant gliomas with In vitro-to-In vivo correlation.

Authors:  Karina Negron; Namir Khalasawi; Billy Lu; Chi-Ying Ho; Jason Lee; Siddharth Shenoy; Hai-Quan Mao; Tza-Huei Wang; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2019-04-09       Impact factor: 9.776

Review 2.  Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders.

Authors:  Elizabeth S Smith; Joshua E Porterfield; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2019-03-04       Impact factor: 15.470

Review 3.  Convection-Enhanced Delivery in Children: Techniques and Applications.

Authors:  K Aquilina; A Chakrapani; L Carr; M A Kurian; D Hargrave
Journal:  Adv Tech Stand Neurosurg       Date:  2022

Review 4.  Nanomedicine for Acute Brain Injuries: Insight from Decades of Cancer Nanomedicine.

Authors:  Rebecca M Kandell; Lauren E Waggoner; Ester J Kwon
Journal:  Mol Pharm       Date:  2020-06-25       Impact factor: 4.939

5.  LentiRILES, a miRNA-ON sensor system for monitoring the functionality of miRNA in cancer biology and therapy.

Authors:  Viorel Simion; Claire Loussouarn; Yoan Laurent; Loris Roncali; David Gosset; Flora Reverchon; Audrey Rousseau; Francisco Martin; Patrick Midoux; Chantal Pichon; Emmanuel Garcion; Patrick Baril
Journal:  RNA Biol       Date:  2021-09-27       Impact factor: 4.766

6.  Perspectives on Nanodelivery to the Brain: Prerequisites for Successful Brain Treatment.

Authors:  Yang Hu; Margareta Hammarlund-Udenaes
Journal:  Mol Pharm       Date:  2020-10-16       Impact factor: 4.939

Review 7.  Intranasal drug delivery: opportunities and toxicologic challenges during drug development.

Authors:  Lea-Adriana Keller; Olivia Merkel; Andreas Popp
Journal:  Drug Deliv Transl Res       Date:  2021-01-25       Impact factor: 4.617

Review 8.  Convection Enhanced Delivery of Topotecan for Gliomas: A Single-Center Experience.

Authors:  Pavan S Upadhyayula; Eleonora F Spinazzi; Michael G Argenziano; Peter Canoll; Jeffrey N Bruce
Journal:  Pharmaceutics       Date:  2020-12-30       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.